Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3years

Epilepsy and Behavior

Volumn 22, Issue 2, 2011, Pages 240-246

  Cohen, Morris J ^a   Meador, Kimford J ^b   Browning, Nancy ^c   Baker, Gus A ^d   Clayton Smith, Jill ^e   Kalayjian, Laura A ^f   Kanner, Andres ^g   Liporace, Joyce D ^h   Pennell, Page B ⁱ   Privitera, Michael ^j   Loring, David W ^d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMMES CORPORATION   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h Neurology   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

Antiepileptic drugs; Behavioral neurology; Carbamazepine; Child development; Epilepsy; Pregnancy; Valproate

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ADAPTIVE BEHAVIOR; ADULT; AGGRESSION; ANTICONVULSANT THERAPY; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; DEPRESSION; DOSE RESPONSE; DRUG EXPOSURE; DRUG SAFETY; EMOTION; EPILEPSY; FEMALE; FUNCTIONAL ASSESSMENT; GESTATIONAL AGE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MONOTHERAPY; MOTOR PERFORMANCE; PREMATURITY; PRENATAL EXPOSURE; PRESCHOOL CHILD; PSYCHOSOCIAL WITHDRAWAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SOCIAL ADAPTATION; SOMATIZATION;

ADAPTATION, PSYCHOLOGICAL; ANTICONVULSANTS; BEHAVIORAL SYMPTOMS; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGRESSION ANALYSIS;

EID: 80053386087     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.06.014     Document Type: Article

References (28)

1. Fisher J.E., Vorhees C.V. Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction. Pharmacol Res 1992, 26:207-221.
2. Gaily E., Meador K.J. Neurodevelopmental effects. Epilepsy: a comprehensive textbook 2007, 1225-1233. Lippincott Williams & Wilkins, Philadelphia. 2nd ed. J. Engel, T.A. Pedley (Eds.).
3. Bittigau P., Sifringer M., Genz K., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002, 99:15089-15094.
4. Bittigau P., Sifringer M., Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci 2003, 993:103-114. discussion 23-4.
5. Glier C., Dzietko M., Bittigau P., Jarosz B., Korobowicz E., Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004, 187:403-409.
6. Katz I., Kim J., Gale K., Kondratyev A. Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 2007, 322:494-500.
7. Kim J.S., Kondratyev A., Tomita Y., Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007, 48(Suppl. 5):19-26.
8. Manthey D., Asimiadou S., Stefovska V., et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005, 193:497-503.
9. Stefovska V.G., Uckermann O., Czuczwar M., et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008, 64:434-445.
10. Adab N., Kini U., Vinten J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004, 75:1575-1583.
11. Gaily E., Kantola-Sorsa E., Hiilesmaa V., et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004, 62:28-32.
12. Meador K.J., Baker G.A., Browning N., et al. Cognitive function at 3years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009, 360:1597-1605.
13. Meador K.J., Baker G.A., Browning N., et al. Fetal antiepileptic drug exposure and verbal vs. nonverbal abilities at age 3. Brain 2011, 134:396-404.
14. Kluger B.M., Meador K.J. Teratogenicity of antiepileptic medications. Semin Neurol 2008, 28:328-335.
15. Harden C.L., Meador K.J., Pennell P.B., et al. Practice Parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009, 73:133-141.
16. Sattler J.M. Assessment of children 1992, Jerome M. Sattler, San Diego. 3rd ed.
17. Hollingshead A.B. Four factor index of social status 1975, Yale Univ., New Haven, CT.
18. Brown L., Sherbenou R.J., Johnsen S.K. Test of Non-verbal Intelligence (TONI-3) 1996, Pro-Ed, Austin, TX. 3rd ed.
19. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI) 1999, Psychological Corp., San Antonio, TX.
20. Nelson H., Willison J. National Adult Reading test (NART) 1991, NFER-Nelson, Oxford.
21. Bayley N. Bayley Scales of Infant Development 1993, Psychological Corp., San Antonio, TX. 2nd ed.
22. Harrison P.L., Oakland T. Adaptive Behavior Assessment System-II 2003, Psychological Corp., San Antonio, TX.
23. Reynolds C., Kamphaus R.W. Behavior Assessment System for Children 1992, American Guidance Service, Circle Pines, MN.
24. Abidin R.R. Parenting Stress Index 1995, Psychological Assessment Resources, Lutz, FL. 3rd ed.
25. Bloom B., Cohen R.A. Summary Health Statistics for U.S. Children: National Health Interview Survey, 2006 2007, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
26. Bromley R.L., Mawer G., Clayton-Smith J., Baker G.A. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008, 71:1923-1924.
27. Vinten J., Bromley R.L., Taylor J., Adab N., Kini U., Baker G.A. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009, 14:197-201.
28. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001, 43:202-206.